Human Genome Epidemiology Literature Finder
Records 1 - 23 (of 23 Records) |
Query Trace: Neoplasms and KLK2[original query] |
---|
Single nucleotide polymorphism of the human kallikrein-2 gene highly correlates with serum human kallikrein-2 levels and in combination enhances prostate cancer detection. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003 Jun 21 (12): 2312-9. Nam Robert K, Zhang William W, Trachtenberg John, Diamandis Eleftherios, Toi Ants, Emami Marjan, Ho Minnie, Sweet Joan, Evans Andrew, Jewett Michael A S, Narod Steven |
Human kallikrein-2 gene polymorphism is associated with the occurrence of prostate cancer. The Journal of urology 2005 Feb 173 (2): 429-32. Chiang Chih-Hung, Hong Chen-Jee, Chang Yen-Hwa, Chang Luke S, Chen Kuang-K |
Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy. Clinical cancer research : an official journal of the American Association for Cancer Research 2006 Nov 12 (21): 6452-8. Nam Robert K, Zhang William W, Klotz Laurence H, Trachtenberg John, Jewett Michael A S, Sweet Joan, Toi Ants, Teahan Seamus, Venkateswaran Vasundara, Sugar Linda, Loblaw Andrew, Siminovitch Kathy, Narod Steven |
Tagging SNPs in the kallikrein genes 3 and 2 on 19q13 and their associations with prostate cancer in men of European origin. Human genetics 2007 Nov 122 (3-4): 251-9. Pal Prodipto, Xi Huifeng, Sun Guangyun, Kaushal Ritesh, Meeks Joshua J, Thaxton C Shad, Guha Saurav, Jin Carol H, Suarez Brian K, Catalona William J, Deka Ranj |
Candidate gene approach evaluates association between innate immunity genes and breast cancer risk in Korean women. Carcinogenesis 2009 Sep 30 (9): 1528-31. Lee Ji-Young, Park Ae Kyung, Lee Kyoung-Mu, Park Sue K, Han Sohee, Han Wonshik, Noh Dong-Young, Yoo Keun-Young, Kim Ho, Chanock Stephen J, Rothman Nathaniel, Kang Daeh |
Generalizability of associations from prostate cancer genome-wide association studies in multiple populations. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 Mar . Waters KM, Le Marchand L, Kolonel LN, Monroe KR, Stram DO, Henderson BE, Haiman CA |
Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China. Environmental and molecular mutagenesis 2009 May 50 (4): 285-90. Shen Min, Vermeulen Roel, Rajaraman Preetha, Menashe Idan, He Xingzhou, Chapman Robert S, Yeager Meredith, Thomas Gilles, Burdett Laurie, Hutchinson Amy, Yuenger Jeff, Chanock Stephen, Lan Qi |
Improved prediction of biochemical recurrence after radical prostatectomy by genetic polymorphisms. The Journal of urology 2010 Aug 184 (2): 506-11. Morote Juan, Del Amo Jokin, Borque Angel, Ars Elisabet, Hernández Carlos, Herranz Felipe, Arruza Antonio, Llarena Roberto, Planas Jacques, Viso María J, Palou Joan, Raventós Carles X, Tejedor Diego, Artieda Marta, Simón Laureano, Martínez Antonio, Rioja Luis |
Susceptibility loci associated with prostate cancer progression and mortality. Clinical cancer research : an official journal of the American Association for Cancer Research 2010 May 16 (10): 2819-32. Gallagher David J, Vijai Joseph, Cronin Angel M, Bhatia Jasmine, Vickers Andrew J, Gaudet Mia M, Fine Samson, Reuter Victor, Scher Howard I, Halldén Christer, Dutra-Clarke Ana, Klein Robert J, Scardino Peter T, Eastham James A, Lilja Hans, Kirchhoff Tomas, Offit Kenne |
Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer. Cancer prevention research (Philadelphia, Pa.) 2010 May 3 (5): 611-9. Klein Robert J, Halldén Christer, Cronin Angel M, Ploner Alexander, Wiklund Fredrik, Bjartell Anders S, Stattin Pär, Xu Jianfeng, Scardino Peter T, Offit Kenneth, Vickers Andrew J, Grönberg Henrik, Lilja Ha |
Exploratory study of a KLK2 polymorphism as a prognostic marker in prostate cancer. Cancer biomarkers : section A of Disease markers 2010 7 (2): 101-8. Kohli Manish, Rothberg Paul G, Feng Changyong, Messing Edward, Joseph Jean, Rao Sreevidya Sadasiva, Hendershot Allison, Sahsrabudhe Deep |
Large-scale exploration of gene-gene interactions in prostate cancer using a multistage genome-wide association study. Cancer research 2011 May 71 (9): 3287-95. Ciampa Julia, Yeager Meredith, Amundadottir Laufey, Jacobs Kevin, Kraft Peter, Chung Charles, Wacholder Sholom, Yu Kai, Wheeler William, Thun Michael J, Divers W Ryan, Gapstur Susan, Albanes Demetrius, Virtamo Jarmo, Weinstein Stephanie, Giovannucci Edward, Willett Walter C, Cancel-Tassin Geraldine, Cussenot Olivier, Valeri Antoine, Hunter David, Hoover Robert, Thomas Gilles, Chanock Stephen, Chatterjee Nilanj |
Genetic predisposition to early recurrence in clinically localized prostate cancer. BJU international 2013 Apr 111 (4): 549-58. Borque Ángel, del Amo Jokin, Esteban Luis M, Ars Elisabet, Hernández Carlos, Planas Jacques, Arruza Antonio, Llarena Roberto, Palou Joan, Herranz Felipe, Raventós Carles X, Tejedor Diego, Artieda Marta, Simon Laureano, Martínez Antonio, Carceller Elena, Suárez Miguel, Allué Marta, Sanz Gerardo, Morote Ju |
Association of Polymorphism rs198977 in Human Kallikrein-2 Gene (KLK2) with Susceptibility of Prostate Cancer: A Meta-Analysis. PloS one 2013 8 (6): e65651. Wang Lishan, Zang Weidong, Sang Yunxia, Xie Dongli, Wei Li, Ji Weidong, Pan Yaosheng, Li Zhiqiang, Shen Jiawei, Shi Yongyo |
Genetic variation in KLK2 and KLK3 is associated with concentrations of hK2 and PSA in serum and seminal plasma in young men. Clinical chemistry 2013 Nov . Sävblom C, Halldén C, Cronin AM, Säll T, Savage C, Vertosick EA, Klein RJ, Giwercman A, Lilja H |
Genome-wide association study identifies loci at ATF7IP and KLK2 associated with percentage of circulating free PSA.
Neoplasia (New York, N.Y.) 2013 Jan 15 (1): 1. Jin G, Zheng SL, Lilja H, Kim ST, Tao S, Gao Z, Young T, Wiklund F, Feng J, Isaacs WB, Rittmaster RS, Gronberg H, Condreay LD, Sun J, Xu J |
Kallikrein 3 and vitamin D receptor polymorphisms: potentials environmental risk factors for prostate cancer. Diagnostic pathology 2014 9 (1): 84. Hu Jianpeng, Qiu Zhen, Zhang Liansheng, Cui Feil |
Human kallikrein-2 gene and protein expression predicts prostate cancer at repeat biopsy. SpringerPlus 2014 3 295. Satkunasivam Raj, Zhang William, Trachtenberg John, Toi Ants, Yu Changhong, Diamandis Eleftherios, Kattan Michael W, Narod Steven A, Nam Robert |
A functional variant in miR-143 promoter contributes to prostate cancer risk. Archives of toxicology 2014 Oct . Chu Haiyan, Zhong Dongyan, Tang Jialin, Li Jie, Xue Yao, Tong Na, Qin Chao, Yin Changjun, Zhang Zhengdong, Wang Meil |
Retraction: Association of Polymorphism rs198977 in Human Kallikrein-2 Gene (KLK2) with Susceptibility of Prostate Cancer: A Meta-Analysis. PloS one 2016 11 (7): e0160298. Authors are not available |
Genetic factors influencing prostate cancer risk in Norwegian men. The Prostate 2017 Nov . Chen Haitao, Ewing Charles M, Zheng Sigun, Grindedaal Eli M, Cooney Kathleen A, Wiley Kathleen, Djurovic Srdjan, Andreassen Ole A, Axcrona Karol, Mills Ian G, Xu Jianfeng, Maehle Lovise, Fosså Sophie D, Isaacs William |
MicroRNA-3162-5p-Mediated Crosstalk between Kallikrein Family Members Including Prostate-Specific Antigen in Prostate Cancer. Clinical chemistry 2019 Apr . Matin Farhana, Jeet Varinder, Srinivasan Srilakshmi, Cristino Alexandre S, Panchadsaram Janaththani, Clements Judith A, Batra Jyotsna, |
Genetic polymorphisms at 19q13.33 are associated with [-2]proPSA (p2PSA) levels and provide additional predictive value to prostate health index for prostate cancer. The Prostate 2021 7 81 (13): 971-982. Huang Da, Ruan Xiaohao, Wu Yishuo, Lin Xiaoling, Huang Jingyi, Ye Dingwei, Gao Yi, Ding Qiang, Xu Danfeng, Na Ro |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: